ERGOMAR Drug Patent Profile
✉ Email this page to a colleague
When do Ergomar patents expire, and when can generic versions of Ergomar launch?
Ergomar is a drug marketed by Pangea and is included in one NDA.
The generic ingredient in ERGOMAR is ergotamine tartrate. There are thirteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the ergotamine tartrate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ERGOMAR?
- What are the global sales for ERGOMAR?
- What is Average Wholesale Price for ERGOMAR?
Summary for ERGOMAR
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 15 |
| Clinical Trials: | 1 |
| Patent Applications: | 4,000 |
| DailyMed Link: | ERGOMAR at DailyMed |
Recent Clinical Trials for ERGOMAR
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Stanford University | Phase 2 |
Pharmacology for ERGOMAR
| Drug Class | Ergotamine Derivative |
US Patents and Regulatory Information for ERGOMAR
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pangea | ERGOMAR | ergotamine tartrate | TABLET;SUBLINGUAL | 087693-001 | Feb 24, 1983 | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
